Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $3.26 up 2.19% from the previous closing price of $3.19. In other words, the price has increased by $2.19 from its previous closing price. On the day, 1.78 million shares were traded. RCKT stock price reached its highest trading level at $3.26 during the session, while it also had its lowest trading level at $3.1365.
Ratios:
For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4.
Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 27 ’25 when Bjork Elisabeth bought 10,000 shares for $3.41 per share. The transaction valued at 34,100 led to the insider holds 40,000 shares of the business.
Militello John sold 699 shares of RCKT for $2,142 on Aug 18 ’25. The insider now owns 56,285 shares after completing the transaction at $3.06 per share. On Aug 19 ’25, another insider, Militello John, who serves as the insider of the company, sold 361 shares for $3.00 each. As a result, the insider received 1,082 and left with 55,924 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 351766624 and an Enterprise Value of 105474616.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.60, which has changed by -0.82349753 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $18.92, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 2.18%, while the 200-Day Moving Average is calculated to be -49.73%.
Shares Statistics:
Over the past 3-months, RCKT traded about 3.83M shares per day on average, while over the past 10 days, RCKT traded about 2443520 shares per day. A total of 107.88M shares are outstanding, with a floating share count of 98.68M. Insiders hold about 8.55% of the company’s shares, while institutions hold 86.16% stake in the company. Shares short for RCKT as of 1757894400 were 14892250 with a Short Ratio of 3.89, compared to 1755216000 on 11725943. Therefore, it implies a Short% of Shares Outstanding of 14892250 and a Short% of Float of 26.87.
Earnings Estimates
. The current assessment of Rocket Pharmaceuticals Inc (RCKT) involves the perspectives of 14.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.69 and -$2.36 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$1.19, with 13.0 analysts recommending between $0.69 and -$2.13.
